Jack Bliss

Jack has advised on the following select matters:

• Advised Colt Technology Services Group on its USD 1.8 billion acquisition of the EMEA businesses of Lumen Technologies, Inc., a US listed company.
• Advised Cellnex Telecoms, S.A. on its EUR 730 million divestment of a 49% stake in its Nordics telecom towers business to Stonepeak.
• Advised New Mountain Capital on its USD 2.5 billion acquisition of the Applied, Food and Enterprise Services business of PerkinElmer, Inc., a US listed company.
• Advised Arcus Infrastructure Partners on the restructuring of its European cold storage solutions portfolio group (valued north of EUR 1 billion), including a management equity roll-up, and various bolt-on acquisitions to same.
• Advised Gulf Data Hub on the partial divestment to, and strategic partnership with, KKR of its Middle East data centre business.
• Advised PETRONAS Chemical Group on its EUR 1.6 billion acquisition of the Perstorp Group, a leading sustainability-driven global specialty chemicals company.

Additionally, whilst on secondment to Bain Capital Private Equity, Jack advised Bain Capital on a number of acquisitions and divestments, including:

• the acquisition of a controlling stake in Somacis, an Italian-headquartered manufacturer of printed circuit boards, from Chequers Capital, and the subsequent add-on acquisition of the AT&S Korea, a medical PCB manufacturer;
• the EUR 4 billion acquisition of Apleona, a leading European provider of integrated facility management, from PAI Partners;
• the acquisition of a controlling stake in Namirial, a leading provider of digital transaction management software solutions, from Ambienta, and the subsequent add-on acquisition of Signaturit from PSG Equity;
• the acquisition of a controlling stake in Softway Medical Group, a European healthcare software provider, from Five Arrows and Naxicap Partners;
• the acquisition by Bain Capital portfolio company Valeo Foods of I.D.C. Holding, a major manufacturer of high-quality sweets products in Slovakia; and
• the GBP 1.3 billion sale of esure, a leading UK personal lines insurer, to Ageas.